Ações Farmacêuticas e biotecnologia

125 empresas neste tema

EmpresaPreçoVar. %Valor de mercadoP/LDividendo
Eli LillyLLY$ 1.415,55−1,13%$ 1,28 tri46,50,5%
Johnson & JohnsonJNJ$ 278,70−1,36%$ 680,19 bi42,91,9%
AbbVieABBV$ 292,82−0,59%$ 517,59 bi50,42,4%
Roche HoldingROPCHF 406,20−0,76%CHF 325,56 bi26,72,4%
Merck & Co.MRK$ 143,37−0,75%$ 356,13 bi144,52,4%
NovartisNOVN · SIXCHF 133,28−1,83%CHF 256,4 bi32,62,8%
AstraZenecaAZN · LSE13.802,00 GBp−1,65%£ 217,66 bi26,61,7%
AmgenAMGN$ 457,93−0,95%$ 250,07 bi26,82,2%
Gilead SciencesGILD$ 170,26+1,60%$ 211,18 bi—1,9%
Novo NordiskNOVO.B · Nasdaq Copenhagenkr 275,50−3,42%kr 1,26 tri11,24,2%
PfizerPFE$ 28,47−1,35%$ 164,5 bi41,26,0%
Vertex PharmaceuticalsVRTX$ 534,20−0,67%$ 135,44 bi34,4—
Bristol-Myers SquibbBMY$ 61,35−2,51%$ 125,4 bi13,64,1%
SanofiSAN · Euronext Paris€ 86,56−1,99%€ 106,04 bi25,54,8%
GSKGSK · LSE1.869,00 GBp−3,14%£ 77,35 bi18,03,7%
Regeneron PharmaceuticalsREGN$ 957,76+0,56%$ 98,52 bi21,10,4%
ModernaMRNA$ 206,80−3,93%$ 87,1 bi——
MerckMRK€ 150,75+0,70%€ 65,09 bi33,91,5%
CSLCSL$ 198,54−0,51%$ 95,48 bi—2,0%
BayerBAYN€ 56,14−1,51%€ 56 bi—0,2%
UCBUCB€ 286,80−2,81%€ 55,69 bi25,70,5%
argenxARGX · NASDAQ$ 947,52−0,36%$ 59,8 bi32,9—
Galderma GroupGALDCHF 187,15−2,02%CHF 43,64 bi64,50,2%
Teva Pharmaceutical IndustriesTEVA$ 42,62+0,12%$ 49,67 bi99,0—
Samsung Biologics207940₩ 1.381.000,00−2,33%₩ 65,83 tri31,2—
Sun Pharmaceutical IndustriesSUNPHARMA · NSE₹ 1.880,00−0,27%₹ 4,48 tri40,90,9%
BeOne MedicinesONC · NASDAQ$ 413,26+0,48%$ 46,98 bi52,7—
HaleonHLN · LSE342,30 GBp−1,27%£ 30,43 bi19,32,1%
Royalty PharmaRPRX$ 68,68+0,23%$ 39,4 bi45,41,4%
BiogenBIIB$ 250,79−0,34%$ 37,07 bi107,2—
Celltrion068270₩ 208.500,00−2,11%₩ 48,81 tri31,40,3%
ZoetisZTS$ 83,48−1,08%$ 33,92 bi14,12,5%
GenmabGMAB · Nasdaq Copenhagenkr 3.502,00−0,77%kr 214,45 bi46,2—
InsmedINSM$ 121,86−0,83%$ 26,96 bi——
Hansoh Pharmaceutical Group3692$ 32,42−2,99%$ 202,62 bi27,61,5%
United TherapeuticsUTHR$ 584,10−0,64%$ 25,04 bi22,2—

Farmacêuticas e biotecnologia em resumo

As empresas farmacêuticas e de biotecnologia pesquisam, desenvolvem e vendem medicamentos, desde grandes fabricantes até biotechs menores com poucos produtos em desenvolvimento.

Os resultados dependem dos estudos clínicos, das aprovações regulatórias e do vencimento de patentes, quando chegam os concorrentes genéricos. Os grandes grupos costumam pagar dividendos; as biotechs jovens raramente o fazem.